Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-11-053340)

Filing Details

Accession Number:: 0001209191-11-053340
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-10-31 16:19:20
Reporting Period:: 2011-10-28

Filing Date:: 2011-10-31
Accepted Time:: 2011-10-31 16:19:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1333170	Nxstage Medical Inc.	NXTM	Electromedical & Electrotherapeutic Apparatus (3845)	043454702

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1519023	Michael Miller	C/O Nxstage Medical, Inc. 439 South Union Street Lawrence MA 01843	President, International	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-10-28	1,250	$0.00	2,087	No	4	M	Direct
Common Stock	Disposition	2011-10-28	413	$23.70	1,674	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2011-10-28	1,250	$0.00	1,250	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,500			No	4	M	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 9, 2011.
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock
Executive was granted a time-based restricted stock unit award of 10,000 shares of common stock of the Company on April 25, 2011, and vesting in equal installments on a quarterly basis over a period of twenty-four months.